Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market

Aug.16.2024
Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market
Fake ZYN nicotine pouches flood the US market, posing serious risks to consumers and prompting concerns about brand integrity.

Special announcement:

Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market
The whistleblower claimed that they have never found a genuine box of ZYN in the four states they visited.


The information in this article comes from online users, and FIRSTS is unable to verify the authenticity of this information. We are simply providing industry news and information quickly and widely.

Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market
An American wholesaler consulted the informant in this article about the source of ZYN products. | Image source: Informant


If you have any objections to the revelations in this article or would like to communicate with us, please feel free to contact us through the following email address: info@2firsts.com.

Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market
Click on the image to read "The Mystery of Counterfeit Nicotine Pouches: Why are Fake Products Proliferating? How to Combat Counterfeit Goods Displacing Genuine Ones?


This article is not responsible for the accuracy of the information disclosed. Readers should maintain a rational mindset while reading and carefully evaluate the information.


In the highly competitive and saturated e-cigarette market, nicotine pouches are gaining attention as an emerging area. However, due to technology patents protection, technological barriers, and regulatory policy uncertainty, the market for nicotine pouches is flooded with counterfeit products. Addressing this issue, 2FIRSTS conducted a thorough analysis in their previous report, "Suspicions of Counterfeiting in the Nicotine Pouch Industry: Why are Fake Products So Common? How to Address the Problem of Bad Money Driving Out Good Money?" The report revealed the risks of counterfeit and compliance in the rapidly growing nicotine pouch market, highlighting the complexities of the market.


After the article was published, a senior figure in the nicotine pouch industry who is currently visiting the US market shared his observations with 2FIRSTS. According to him, counterfeit versions of the well-known brand ZYN are rampant in New York, New Jersey, Virginia, and Arizona. He described the situation as alarming, stating that during his visits he did not come across a single authentic box of ZYN in any of these four states.


Counterfeit ZYN products are now being sold in several states in the United States at twice the price of VELO.


According to reports, in the American market, in addition to the ZYN brand, there are also other nicotine pouch brands such as ROGUE, VELO, ON!, and FRE. However, ZYN is not only the most widely available brand, but also the most rampant in terms of counterfeit products.


ZYN, acquired by Philip Morris International (PMI) from Swedish Match, saw its shipment volume of nicotine pouches reach 266.7 million cans in the first half of 2024, representing a 63.5% year-on-year increase, as indicated in its performance report.


The sharp increase in sales has led to a market imbalance of supply and demand. According to industry insiders, counterfeit ZYN products are widely distributed in various retail terminals such as convenience stores, tobacco shops, e-cigarette stores, and gas stations, with prices ranging from $6.99 to $9.99, similar to authentic products. However, the nicotine pouch brand VELO, owned by British American Tobacco, is priced at only $4.99, while FRE is priced at just $2.99.


The appearance is so real that it is difficult to distinguish, and the taste is described as "sugar-like.


What is even more worrying is that these counterfeits closely resemble the authentic products in terms of appearance, including box design, color combinations, and material textures, making it almost impossible to distinguish between the two. As a result, not only do average consumers struggle to identify the authenticity of products, but even most shop owners lack a clear understanding of the authenticity of the goods they sell.


Although distinguishing between real and fake ZYN can be difficult, industry insiders have provided a viable method. They point out that the bottom of the box of ZYN contains a QR code, which consumers can scan after purchasing the genuine product to directly access the official ZYN website. If the QR code scanned is for a counterfeit product, it will first redirect to an unknown website before potentially redirecting to the ZYN official website.


In addition, authenticity can also be discerned through the use of experience. According to him, counterfeit ZYN products have significant differences in user experience compared to the genuine ones, with the fakes giving a feeling "like candy." He speculated that these imitation products may not contain any nicotine at all, or only contain a small amount of nicotine, in order to reduce production costs.


Where do counterfeit products come from?


In the article "Suspicions of Nicotine Pouch Counterfeiting: Why are Fake Products Frequently Emerging? How to Combat Bad Money Drives Out Good Money?" 2FIRSTS once held in-depth discussions with industry experts on this issue. At that time, several industry insiders pointed out that China is one of the sources of counterfeit nicotine pouches.


According to the investigation conducted by the aforementioned sources, the conclusion is unanimous - the majority of counterfeit ZYN products originate from manufacturers in China. Some American wholesalers even inquired about the supply chain for ZYN pouches and bluntly stated, "Everyone making zyn in china now.


However, it is understood that ZYN's official production facility is located in Sweden. Philip Morris International (PMI) announced in July of this year that a new ZYN production plant will be built in Colorado, USA. Currently, there are no officially authorized contract factories in China.


This phenomenon has already raised concerns among some industry insiders in the United States, who worry that as brands continue to expand, the issue of counterfeit goods may also arise. As mentioned by the aforementioned individuals, a client who has already obtained PMTA certification raised the question to him: if they were to manufacture products in China, would they also face the risk of being counterfeited as their business grows.


An expert in the emerging tobacco industry stated that from an industry perspective, nicotine pouches as a new form of nicotine consumption have always been controversial, especially in terms of their use by young people and health impacts. The issue of counterfeit products may exacerbate these concerns, prompting regulatory agencies and public health experts to more closely scrutinize this market.


At the same time, for legitimate manufacturers, the proliferation of counterfeit goods could damage their brand image and force them to invest more resources to protect their intellectual property and consumer rights.


For industries in China, this approach will lead to a severe lack of trust in Chinese-made nicotine pouch products overseas, causing incalculable damage to the industry's progress and development.


2FIRSTS will continue to monitor the counterfeit nicotine pouch incident and provide timely updates on the latest developments.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Philip Morris International (PMI) is expanding the international footprint of BONDS by IQOS, its lower-priced heated tobacco platform. The company's third-quarter 2026 SEC filing shows that BONDS devices and BLENDS tobacco sticks were available in 15 markets at the end of September, up from eight at the end of June. In November, PMI announced plans to extend sales from three to 17 Japanese prefectures and introduced BONDS in Spain and Morocco. The platform uses ROUNDHEAT external heating technology and proprietary tobacco sticks, separate from the IQOS ILUMA system. In Japan, BONDS retails for ¥2,980, approximately 25% below ILUMA i ONE, while BLENDS costs ¥570 per pack. PMI management says BONDS targets cigarette smokers who have not adopted heated tobacco. Separate sales and revenue figures remain undisclosed.
company
Nov.06
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26
Russia's Vape Ban Decisions Reach 17 Regions With 39 More Considering Laws, Putting Over 3,000 St. Petersburg Retail Outlets in Focus
Russia's Vape Ban Decisions Reach 17 Regions With 39 More Considering Laws, Putting Over 3,000 St. Petersburg Retail Outlets in Focus
Russia's regional vape retail restrictions are expanding. State Duma Speaker Vyacheslav Volodin said on November 7 that 17 regions had adopted decisions to ban vape sales, while another 39 were preparing or considering similar legislation. On November 12, lawmakers in Leningrad Oblast and the Republic of Karelia adopted bans scheduled to begin on March 1, 2027. A day earlier, St. Petersburg unanimously approved a five-year ban proposal in its first reading. The city has 615 specialist vape shops and more than 2,400 other retail outlets selling vaping products alongside other goods. Under Federal Law No. 186-FZ, enacted in June 2026, Russian regions may prohibit retail sales of electronic nicotine delivery systems and related liquids between March 2027 and March 2032. The legislation also restricts licensed suppliers from delivering covered products to retail premises in regions where bans apply.
Regulations
Nov.13